HEMACELL
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.
HEMACELL
Industry:
Biotechnology Pharmaceutical
Founded:
2021-06-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.xuejibio.com
Status:
Active
Contact:
1-400-800-2526
Email Addresses:
[email protected]
Total Funding:
15.83 M USD
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Investors List
WeDo Capital Management
WeDo Capital Management investment in Series A - HemaCell
Lucion
Lucion investment in Series A - HemaCell
Tairong Capital
Tairong Capital investment in Series A - HemaCell
Guanfang Capital
Guanfang Capital investment in Series A - HemaCell
Founder H Fund
Founder H Fund investment in Series A - HemaCell
Country Garden Venture Capital
Country Garden Venture Capital investment in Series A - HemaCell
Laurel Venture Capital
Laurel Venture Capital investment in Series A - HemaCell
Yuanhe Holding
Yuanhe Holding investment in Seed Round - HemaCell
Country Garden Venture Capital
Country Garden Venture Capital investment in Seed Round - HemaCell
Northern Light Venture Capital
Northern Light Venture Capital investment in Seed Round - HemaCell
Official Site Inspections
http://www.xuejibio.com
- Host name: 154.39.70.72
- IP address: 154.39.70.72
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
